CANTAB BIOPHARMACEUTICALS

cantab-biopharmaceuticals-logo

Cantab Biopharmaceuticals Ltd is a drug development company focused on the development of "biosuperior" products. Based on Cambridge Science Park, Cantab is at the heart of the largest biotech cluster in Europe. Cantab is using it's extensive experience in biopharmaceutical discovery, process development and GMP manufacturing to expedite the development of biosuperiors from inception through clinical development. Previously marketed, off-patent, biologics will be enhanced by the applicatio... n of appropriate cutting-edge technologies in protein expression/engineering, process/manufacturing technology, protein conjugation, formulation and drug delivery. Particular areas of drug characteristics that Cantab seek to improve upon are product presentation and stability, pharmacokinetics, pharmacodynamics, immunogenicity and drug delivery.

#SimilarOrganizations #People #Financial #Website #More

CANTAB BIOPHARMACEUTICALS

Industry:
Biopharma Biotechnology Manufacturing Pharmaceutical

Founded:
2006-01-01

Address:
Cambridge, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.cantabbio.com

Total Employee:
11+

Status:
Active

Contact:
44 1223 423 413

Email Addresses:
[email protected]

Total Funding:
8.1 M USD

Technology used in webpage:
Nginx Baidu Analytics Dingfeng Xinhui


Similar Organizations

biotrack-logo

Biotrack

Biotrack is a Systems for the rapid detection of bacteria in various industries and applications.

fedora-pharmaceuticals-logo

Fedora Pharmaceuticals

Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.

not_available_image

McSAF SAS

Start-Up specialized in BioOrganic Chemistry & BioConjugates (Antibody Drug Conjugates)

morria-biopharmaceuticals-logo

Morria Biopharmaceuticals

Morria Biopharmaceuticals engages in the discovery and development of multi-functional anti-inflammatory drugs.

next-biomed-logo

Next Biomed

Next Biomed engages in the development of bispecific and multispecific therapeutic antibodies.

not_available_image

OrganoTherapeutics

OrganoTherapeutics use mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease.

not_available_image

R&D Biopharmaceuticals

R&D Biopharmaceuticals engages in the pre-clinical and clinical development of small molecules deriving from natural products for diseases.

Current Employees Featured

not_available_image

Victoria Allen
Victoria Allen Finance & HR Manager @ Cantab Biopharmaceuticals
Finance & HR Manager

not_available_image

Jim Mills
Jim Mills CEO @ Cantab Biopharmaceuticals
CEO

john-shields_image

John Shields
John Shields Senior Vice President @ Cantab Biopharmaceuticals
Senior Vice President

Investors List

celtic-pharma_image

Celtic Pharma

Celtic Pharma investment in Venture Round - Cantab Biopharmaceuticals

Official Site Inspections

http://www.cantabbio.com

Unable to get host informations!!!

Loading ...

More informations about "Cantab Biopharmaceuticals"

Management Team :: Cantabio Pharmaceuticals Inc.

Thomas Sawyer, Ph.D., M.B.A. Chief Financial Officer. Dr. Thomas Sawyer is the Chief Financial Officer of Cantabio Pharmaceuticals, combining a background in academic research with 13 years of experience in entrepreneurship, …See details»

About Cantabio Pharmaceuticals

See details»

Cantabio Pharmaceuticals - Crunchbase Company Profile & Funding

Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company focusing on commercializing novel therapies and the intellectual property generated from their research …See details»

Cantabio Pharmaceuticals - Contacts, Employees, Board Members, …

Cantabio Pharmaceuticals has 1 current employee profile, Chief Executive Officer, Chief Scientific Officer and Founder Gergely Tóth. Contacts Edit Contacts SectionSee details»

Cantabio Pharmaceuticals Company Profile - Office Locations ...

Oct 28, 2024 Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and …See details»

Cantabio Pharmaceuticals - PitchBook

Cantabio Pharmaceuticals General Information Description. Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on …See details»

Cantabio Pharmaceuticals - Funding, Financials, Valuation

Aug 17, 2023 Cantabio Pharmaceuticals is funded by Michael J. Fox Foundation. Funding Rounds. Edit Funding Rounds Section. ... This was a Grant round raised on Aug 17, 2023. …See details»

Cantabio Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

Explore Cantabio Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 12 news, and 5 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»

Cantabio Pharmaceuticals - Overview, News & Similar companies ...

Oct 20, 2019 Cantabio Pharmaceuticals and LIH collaborate on the therapeutic targeting of DJ-1 (Luxembourg Institute of Health) Cantabio Pharmaceuticals, Inc., a preclinical stage …See details»

Cantabio Pharmaceuticals | Singapore Biomedtech Incubator …

Cantabio Pharmaceuticals is focused on bringing novel, first-in-class drug candidates and diagnostics into clinical trials and beyond for Parkinson’s, Alzheimer and Diabetic Kidney …See details»

Partnerships :: Cantabio Pharmaceuticals Inc.

Cantabio pharmaceuticals’network of collaborators combine to produce a powerful strategic research advantage. Through our relationships with leading academic research groups we are …See details»

Cantabio Pharmaceuticals Inc. in Palo Alto, CA - (844) 200-2826

Cantabio Pharmaceuticals Inc. is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»

Successful collaboration between Cantabio and NovAliX

Apr 12, 2016 Cantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Ab Peptide for the Treatment of Alzheimer’s Disease in Collaboration with …See details»

CANTABIO PHARMACEUT by Cantabio Pharmaceuticals Inc.

Cantabio Pharmaceuticals, Inc. is a preclinical stage biotechnology company, which engages in the commercialization of novel therapies and the intellectual property generated from the …See details»

Scientific Advisors :: Cantabio Pharmaceuticals Inc.

Nov 13, 2019 Cantabio Announces Publication of Novel Study Demonstrating the Importance of the DJ-1 Protein in the Onset and Pathology of Alzheimer's and Parkinson's disease About …See details»

Cantabio Pharmaceuticals, Inc. (Cantabio Pharmaceuticals, Inc.)

了解Cantabio Pharmaceuticals, Inc. (Cantabio Pharmaceuticals, Inc.)公司的药物管线,治疗领域,技术平台,以及它的12篇新闻和5篇文献,疾病领域:神经系统疾病,内分泌与代谢疾病,技 …See details»

Overview :: Cantabio Pharmaceuticals Inc.

Cantabio strategically integrates therapeutic focus, target family biophysics, novel drug discovery technologies and expertise into an innovative drug discovery approach, producing a constant …See details»

Cantabio Pharmaceuticals Inc News (CTBO) - Investing.com

Get today's Cantabio Pharma stock news. We cover the latest Cantabio Pharma headlines and breaking news impacting Cantabio Pharma stock performance.See details»

Cantabio Pharmaceuticals Announces the Development of Small …

About Cantabio Pharmaceuticals, Inc. Cantabio is focused on bringing novel, first in class drug candidates into clinical trials and beyond through the discovery and development of innovative …See details»

linkstock.net © 2022. All rights reserved